-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Nutriband (NASDAQ:NTRB) and Cadre (NYSE:CDRE) Head-To-Head Analysis
Nutriband (NASDAQ:NTRB) and Cadre (NYSE:CDRE) Head-To-Head Analysis
Nutriband (NASDAQ:NTRB – Get Rating) and Cadre (NYSE:CDRE – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.
Profitability
This table compares Nutriband and Cadre's net margins, return on equity and return on assets.
Get Nutriband alerts:Net Margins | Return on Equity | Return on Assets | |
Nutriband | -321.58% | -40.78% | -37.55% |
Cadre | 0.80% | 3.86% | 1.36% |
Insider & Institutional Ownership
2.1% of Nutriband shares are owned by institutional investors. Comparatively, 34.1% of Cadre shares are owned by institutional investors. 40.2% of Nutriband shares are owned by insiders. Comparatively, 52.9% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Risk & Volatility
Nutriband has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Comparatively, Cadre has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500.Analyst Ratings
This is a breakdown of current recommendations and price targets for Nutriband and Cadre, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Nutriband | 0 | 0 | 0 | 0 | N/A |
Cadre | 0 | 0 | 4 | 0 | 3.00 |
Cadre has a consensus target price of $32.80, indicating a potential upside of 45.45%. Given Cadre's higher possible upside, analysts plainly believe Cadre is more favorable than Nutriband.
Earnings and Valuation
This table compares Nutriband and Cadre's top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Nutriband | $1.42 million | 19.69 | -$6.18 million | ($0.80) | -4.45 |
Cadre | $427.29 million | 1.97 | $12.66 million | $0.08 | 281.91 |
Cadre has higher revenue and earnings than Nutriband. Nutriband is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.
Summary
Cadre beats Nutriband on 12 of the 13 factors compared between the two stocks.
About Nutriband
(Get Rating)
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.
About Cadre
(Get Rating)
Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies. The company was founded in 1964 and is headquartered in Jacksonville, Florida.
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
Nutriband (NASDAQ:NTRB )和Cadre (NYSE:CDRE )都是小盘医疗公司,但哪一个才是更好的投资选择?我们将根据这两家公司的分析师建议、估值、机构所有权、股息、盈利能力、收益和风险的强弱对它们进行比较。
盈利能力
下表比较了Nutriband和Cadre的净利润率、股本回报率和资产回报率。
到达Nutriband警报:
净利润率 | 股本回报率 | 资产回报率 | |
Nutriband | -321.58% | -40.78% | -37.55% |
Cadre Holdings | 0.80% | 3.86% | 1.36% |
内部人与机构所有权
2.1%的Nutriband股份由机构投资者持有。相比之下,34.1%的干部股份由机构投资者持有。Nutriband 40.2%的股份由内部人士持有。相比之下,52.9%的干部股份由内部人持有。强大的机构持股表明,对冲基金、捐赠基金和大型基金管理公司相信,一家公司的长期表现将好于大盘。
风险与波动性
Nutriband的贝塔系数为0.61,表明其股价的波动性比标准普尔500指数低39%。相比之下,Cadre的贝塔系数为1.64,这表明其股价的波动性比标准普尔500指数高64%。
分析师评级
这是MarketBeat提供的对Nutriband和Cadre的当前建议和目标价格的细目。
销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
Nutriband | 0 | 0 | 0 | 0 | 不适用 |
Cadre Holdings | 0 | 0 | 4 | 0 | 3.00 |
Cadre的一致目标价为32.80美元,表明潜在上行空间为45.45%。考虑到干部更有可能的上行空间,分析师们显然认为干部比Nutriband更有利。
收益和估值
下表比较了Nutriband和Cadre的营收、每股收益和估值。
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
Nutriband | 142万美元 | 19.69 | -618万元 | ($0.80) | -4.45 |
Cadre Holdings | 4.2729亿美元 | 1.97 | 1266万美元 | $0.08 | 281.91 |
Cadre的收入和收入都高于Nutriband。Nutriband的市盈率低于Cadre,表明它目前是两只股票中更负担得起的一只。
摘要
在两只股票比较的13个因素中,Cadre有12个胜过Nutriband。
关于Nutriband
(获取评级)
Nutriband,Inc.致力于开发一系列透皮药物产品。它提供滥用威慑芬太尼透皮系统,为临床医生和患者提供用于治疗慢性疼痛的缓释芬太尼透皮产品。它通过Pocono涂层产品和Active Intelligence细分市场运营。该公司由Gareth R.Sheridan和Serguei Melnik于2012年创立,总部位于佛罗里达州奥兰多。
关于Cadre Holdings
(获取评级)
Cadre Holdings,Inc.制造和分销安全和生存能力设备,为美国和世界各地的危险或生命威胁情况下的用户提供保护。该公司在产品和分销两个领域开展业务。该公司主要提供防弹衣产品,如Safarland和Protech Tactical品牌的可隐藏、修正和战术装甲;针对炸弹安全技术人员的救生服、遥控车辆、专用工具、爆炸传感器、配件和车辆减爆座椅;防弹服;包括安全带和配件在内的值班装备;以及其他保护和执法设备,包括通信装备、法医和调查产品、枪支清洗解决方案和人群控制产品。该公司还提供第三方产品,如制服、眼镜、靴子、枪支和弹药。它为州和地方执法、消防和救援、爆炸物处理技术人员、紧急医疗技术人员、渔业和野生动物执法和惩戒部门等急救人员以及包括美国国务院、美国国防部、美国内政部、美国司法部、美国国土安全部、美国惩教部和各种外国政府机构在内的联邦机构提供服务。该公司成立于1964年,总部设在佛罗里达州杰克逊维尔。
接受Nutriband Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Nutriband和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧